Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > E-Selectin


Brief Information

Name:Selectin E
Target Synonym:LECAM2,ELAM1,Endothelial leukocyte adhesion molecule 1,ELAM-1,SELE,Selectin E,CD62 Antigen-Like Family Member E,Endothelial Adhesion Molecule 1,Leukocyte-Endothelial Cell Adhesion Molecule 2,CD62E Antigen,CD62E,ESEL,ELAM,E-Selectin,Leukocyte Endothelial Cell Adhesion Molecule 2
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:4
Lastest Research Phase:Phase 3 Clinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
CDE-H5250 Human Human E-Selectin / CD62E Protein, Fc Tag
CDE-H5222 Human Human E-Selectin / CD62E Protein, His Tag
ACRO Quality

Synonym Name



E-Selectin is also known as CD62 antigen-like family member E (CD62E), endothelial-leukocyte adhesion molecule 1 (ELAM-1), or leukocyte-endothelial cell adhesion molecule 2 (LECAM2), a member of the Selectin family, is a 107-115 kDa cell surface glycoprotein. It is transiently expressed on vascular endothelial cells in response to IL-1β and TNFα. E selectin has a cassette structure: an N-terminal, C-type lectin domain, an EGF (epidermal-growth-factor)-like domain, 6 Sushi domain (SCR repeat) units, a transmembrane domain (TM) and an intracellular cytoplasmic tail (cyto). During inflammation, E-selectin plays an important part in recruiting leukocytes to the site of injury. The local release of cytokines IL-1 and TNF-α by damaged cells induces the over-expression of E-selectin on endothelial cells of nearby blood vessels. E-selectin mediates the adhesion of tumor cells to endothelial cells, by binding to E-selectin ligands expressed by neutrophils, monocytes, eosinophils, memory-effector T-like lymphocytes, natural killer cells or cancer cells. Furthermore, a number of studies have reported that levels of E-Selectin may be elevated in subjects with a variety of pathological conditions.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Uproleselan GMI-1271; APL-106 Phase 3 Clinical Glycomimetics Inc Leukemia; Down Syndrome; Myelodysplastic Syndromes; Coronavirus Disease 2019 (COVID-19); Neoplasms; Multiple Myeloma; Leukemia, Myeloid, Acute; Venous Thrombosis; Leukemia, Biphenotypic, Acute Details
Rivipansel Sodium PF-6460031; PF-06460031-02; PF-06460031 (free base); GM-1070; GMI-1070 Phase 3 Clinical Glycomimetics Inc Pain; Kidney Diseases; Anemia, Sickle Cell Details
E-selectin targeting humanized antibody (LifeArc) Phase 1 Clinical Lifearc Sepsis; Respiratory Distress Syndrome, Adult Details
GMI-1687 GMI-1687 Phase 1 Clinical Glycomimetics Inc Leukemia, Myeloid, Acute Details

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message